Engineered Cell Therapies – Potential And Development Of Non-Viral Methods
Source: Miltenyi Biotec
Lea-Isabell Schwarze, a group of Prof. Fehse, Hamburg, and Dr. Tatjana Cornu, Freiburg give insights into their work and experiences developing a non-viral gene editing process and transferring it to GMP.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Miltenyi Biotec
This website uses cookies to ensure you get the best experience on our website. Learn more